Cryocell International Stock Probability of Future Stock Price Finishing Under 8.36
| CCEL Stock | USD 9.09 0.09 1.00% |
CryoCell |
CryoCell International Target Price Odds to finish below 8.36
The tendency of CryoCell Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 8.36 or more in 90 days |
| 9.09 | 90 days | 8.36 | more than 94.0 |
Based on a normal probability distribution, the odds of CryoCell International to drop to $ 8.36 or more in 90 days from now is more than 94.0 (This CryoCell International probability density function shows the probability of CryoCell Stock to fall within a particular range of prices over 90 days) . Probability of CryoCell International price to stay between $ 8.36 and its current price of $9.09 at the end of the 90-day period is about 5.01 .
Given the investment horizon of 90 days CryoCell International has a beta of -0.15 suggesting as returns on the benchmark increase, returns on holding CryoCell International are expected to decrease at a much lower rate. During a bear market, however, CryoCell International is likely to outperform the market. Additionally CryoCell International has an alpha of 0.6561, implying that it can generate a 0.66 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). CryoCell International Price Density |
| Price |
Predictive Modules for CryoCell International
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CryoCell International. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of CryoCell International's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
CryoCell International Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. CryoCell International is not an exception. The market had few large corrections towards the CryoCell International's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CryoCell International, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CryoCell International within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.66 | |
β | Beta against Dow Jones | -0.15 | |
σ | Overall volatility | 1.03 | |
Ir | Information ratio | 0.11 |
CryoCell International Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CryoCell International for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CryoCell International can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| CryoCell International appears to be risky and price may revert if volatility continues | |
| CryoCell International currently holds 10.9 M in liabilities with Debt to Equity (D/E) ratio of 0.26, which may suggest the company is not taking enough advantage from borrowing. CryoCell International has a current ratio of 0.46, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about CryoCell International's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 31.34 M. Net Loss for the year was (9.52 M) with profit before overhead, payroll, taxes, and interest of 21.54 M. | |
| CryoCell International has a poor financial position based on the latest SEC disclosures | |
| About 48.0% of CryoCell International shares are held by company insiders | |
| On 30th of November 2024 CryoCell International paid $ 0.25 per share dividend to its current shareholders | |
| Latest headline from MacroaxisInsider: Disposition of 10000 shares by Oleg Mikulinsky of CryoCell International at 4.34 subject to Rule 16b-3 |
CryoCell International Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of CryoCell Stock often depends not only on the future outlook of the current and potential CryoCell International's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CryoCell International's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 8.3 M | |
| Cash And Short Term Investments | 980.2 K |
CryoCell International Technical Analysis
CryoCell International's future price can be derived by breaking down and analyzing its technical indicators over time. CryoCell Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of CryoCell International. In general, you should focus on analyzing CryoCell Stock price patterns and their correlations with different microeconomic environments and drivers.
CryoCell International Predictive Forecast Models
CryoCell International's time-series forecasting models is one of many CryoCell International's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary CryoCell International's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about CryoCell International
Checking the ongoing alerts about CryoCell International for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for CryoCell International help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| CryoCell International appears to be risky and price may revert if volatility continues | |
| CryoCell International currently holds 10.9 M in liabilities with Debt to Equity (D/E) ratio of 0.26, which may suggest the company is not taking enough advantage from borrowing. CryoCell International has a current ratio of 0.46, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about CryoCell International's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 31.34 M. Net Loss for the year was (9.52 M) with profit before overhead, payroll, taxes, and interest of 21.54 M. | |
| CryoCell International has a poor financial position based on the latest SEC disclosures | |
| About 48.0% of CryoCell International shares are held by company insiders | |
| On 30th of November 2024 CryoCell International paid $ 0.25 per share dividend to its current shareholders | |
| Latest headline from MacroaxisInsider: Disposition of 10000 shares by Oleg Mikulinsky of CryoCell International at 4.34 subject to Rule 16b-3 |
Check out CryoCell International Backtesting, CryoCell International Valuation, CryoCell International Correlation, CryoCell International Hype Analysis, CryoCell International Volatility, CryoCell International History as well as CryoCell International Performance. For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.625 | Earnings Share (1.07) | Revenue Per Share 3.89 | Quarterly Revenue Growth 0.025 | Return On Assets (0) |
The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.